Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Cardiac Function Suppliers In Europe
8 companies found
based inBrussels, BELGIUM
Surveal is a Belgian nutraceuticals company, founded in 2011, that is specialized in developing and manufacturing premium quality dietary supplements for a variety of lifestyle-enhancing purposes, as well as a range of nutraceutical hygiene and ...
Your Cholesterol In “Balance With Nature”. Cholesterol is essential for our body, but when present in excess, it can be harmful. Although a varied and balanced diet helps maintain normal cholesterol levels, a proportion of endogenous ...
based inLondon, UNITED KINGDOM
Acurable is a venture-backed, fast growing, medical devices company, with offices in London and Seville. We create accurate, but very user-friendly, wearable medical devices intended to be used by patients themselves at home. Our first family of ...
Clinically validated: AcuPebble SA100 automated sleep apnea test was validated in a powered clinical trial at the NHS Royal Free London hospital. Validated sleep study result equivalent to ambulatory gold-standard (multi-channel polygraphy followed ...
based inLeiden, NETHERLANDS
Medis was created in 1989 as a spin-off of the Leiden University Medical Centre (LUMC Netherlands). Our founder and current CSO, Hans Reiber, built the company focusing on X-ray and image analysis of the heart with the mission to make these tools ...
The innovative, vendor-independent post-processing software solution for advanced quantitative analysis of cardiovascular CT ...
based inVienna, AUSTRIA
Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be ...
Discussions are underway for the design of a clinical program in this indication together with a manufacturer of catheter devices suitable for direct myocardial injection of APO-1 ...
based inDurham, NORTH CAROLINA (USA)
At TeraRecon, our mission is to continuously innovate ahead of market demand to provide solutions that impact clinical care across health systems. As a partner with our customers, TeraRecon helps to establish an organization's vision and provide ...
TeraRecon is continually innovating to bring the industry the latest in AV capabilities! Intuition 4.6 includes Dual Monitor Support, Patient List Filtering, Glow Rendering, New Measurement Tools, HL7 Communication Protocol, and an all-new Neuro ...
based inAwans, BELGIUM
Miracor Medical is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Miracor develops and studies the PICSO® (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System ...
based inTeltow, GERMANY
GETEMED, located in Teltow, Brandenburg, has been developing, manufacturing and selling medical devices in the fields of cardiological diagnostics and vital signs monitoring for over 35 years. GETEMED Medizin- und Informationstechnik AG, with ...
Simple, fast, and reliable – that’s what our customers look for when it comes to recording and analyzing Holter ECGs. The lightweight, easy to use, CardioMem® CM 4000 recorder supports the user throughout all phases of ECG ...
based inMulhouse, FRANCE
CellProthera is a biotech company, incorporated in April 2008, and intended for the development, registration and marketing of innovative therapeutic solutions for the regeneration of organs damaged by disease or trauma from autologous blood ...
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to ...